RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Total current liabilities

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.4B
P/E ratio
-3.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 2025132-31.07%
Mar 31, 2024191+149.50%
Mar 31, 202377-58.54%
Mar 31, 2022185+18.06%
Mar 31, 2021156-9.52%
Mar 31, 2020173+16.16%
Mar 31, 2019149-35.05%
Mar 31, 2018229+42.07%
Mar 31, 2017161+25.11%
Mar 31, 2016129-27.95%
Mar 31, 2015179

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)